NEW RESEARCH
Our research with Psoriasis has shown that by restoring normal cellular responses in the skin, it is possible to retrain the immune system so that it responds in an appropriate way to challenge. This clearly has application in restoring normal cellular function in a range of autoimmune and inflammatory diseases. We have research programs looking at improving the quality of life of people living with the following conditions. Although research is at an early stage we have a number of experimental formulation which may benefit specific aspects of these conditions. If you are unable to obtain relief from existing medications please contact Peak for a confidential discussion and possible experimental use of these formulations. Peak is committed to helping all individuals.
IMPORTANT NEW RECENT RESEARCH
Journal of Clinical Investigation Vol.104 p375 has shown that the genetic disease
Duchennes Mucsular Dystraphy can be treated with the antibiotic gentamicin. You should contact your doctor for details.MS
A controversial paper published in Annals of Neurology vol 46 p6 has shown that Chlamydia pneumoniae might be linked to
MULTIPLE SCLEROSIS. We would strongly recommend that MS sufferers consult their medical practitioners about this paper. Treatment for this bacteria is a common antibiotic and there is some evidence to suggest that rapid improvement in symptoms is possible with no side effects.LUPUS/SLE, MULTIPLE SCLEROSIS and MUSCULAR DYSTROPHY